269 related articles for article (PubMed ID: 23095091)
1. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.
Mumphrey MB; Patterson LM; Zheng H; Berthoud HR
Neurogastroenterol Motil; 2013 Jan; 25(1):e70-9. PubMed ID: 23095091
[TBL] [Abstract][Full Text] [Related]
2. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
[TBL] [Abstract][Full Text] [Related]
3. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.
Egerod KL; Engelstoft MS; Grunddal KV; Nøhr MK; Secher A; Sakata I; Pedersen J; Windeløv JA; Füchtbauer EM; Olsen J; Sundler F; Christensen JP; Wierup N; Olsen JV; Holst JJ; Zigman JM; Poulsen SS; Schwartz TW
Endocrinology; 2012 Dec; 153(12):5782-95. PubMed ID: 23064014
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.
Hansen CF; Bueter M; Theis N; Lutz T; Paulsen S; Dalbøge LS; Vrang N; Jelsing J
PLoS One; 2013; 8(6):e65696. PubMed ID: 23776529
[TBL] [Abstract][Full Text] [Related]
5. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
[TBL] [Abstract][Full Text] [Related]
6. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
[TBL] [Abstract][Full Text] [Related]
7. The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats.
Zhang C; Rigbolt K; Petersen SL; Biehl Rudkjær LC; Schwahn U; Fernandez-Cachon ML; Bossart M; Falkenhahn M; Theis S; Hübschle T; Schmidt T; Just Larsen P; Vrang N; Jelsing J
Peptides; 2019 Aug; 118():170100. PubMed ID: 31212005
[TBL] [Abstract][Full Text] [Related]
8. Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls.
Martinussen C; Dirksen C; Bojsen-Møller KN; Svane MS; Carlsson ER; Hartmann B; Clausen TR; Veedfald S; Kristiansen VB; Rehfeld JF; Hansen HS; Holst JJ; Madsbad S
Am J Clin Nutr; 2020 Jan; 111(1):28-41. PubMed ID: 31742316
[TBL] [Abstract][Full Text] [Related]
9. CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.
Modvig IM; Christiansen CB; Rehfeld JF; Holst JJ; Veedfald S
Physiol Rep; 2020 Jan; 8(2):e14352. PubMed ID: 31984675
[TBL] [Abstract][Full Text] [Related]
10. Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet.
Wallenius V; Elias E; Elebring E; Haisma B; Casselbrant A; Larraufie P; Spak E; Reimann F; le Roux CW; Docherty NG; Gribble FM; Fändriks L
Gut; 2020 Aug; 69(8):1423-1431. PubMed ID: 31753852
[TBL] [Abstract][Full Text] [Related]
11. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
[TBL] [Abstract][Full Text] [Related]
12. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
[TBL] [Abstract][Full Text] [Related]
13. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
14. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Prada-Oliveira JA
Obes Surg; 2022 Dec; 32(12):4023-4032. PubMed ID: 36301409
[TBL] [Abstract][Full Text] [Related]
15. RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limb.
Sridhar A; Khan D; Elliott JA; Naughton V; Flatt PR; Irwin N; Moffett CR
PLoS One; 2023; 18(5):e0286062. PubMed ID: 37228045
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Steinert RE; Feinle-Bisset C; Asarian L; Horowitz M; Beglinger C; Geary N
Physiol Rev; 2017 Jan; 97(1):411-463. PubMed ID: 28003328
[TBL] [Abstract][Full Text] [Related]
17. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
18. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
19. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
